These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23352458)

  • 1. Is the HCV pipeline heading in the right direction?
    Aronsohn A; Muir AJ; Swan T; Jensen D
    Gastroenterology; 2013 Mar; 144(3):482-5. PubMed ID: 23352458
    [No Abstract]   [Full Text] [Related]  

  • 2. The successful use of telaprevir to treat hepatitis C recurrence after liver transplantation in an HIV co-infected patient.
    Alkhouri N; Singh G; Carey WD; Fung JJ; Zein NN; Eghtesad B; Taege A
    Transplantation; 2014 Jan; 97(2):e14-5. PubMed ID: 24434485
    [No Abstract]   [Full Text] [Related]  

  • 3. Prompt arrival of antivirals against hepatitis C for HIV patients.
    Barreiro P; Vispo E
    AIDS Rev; 2010; 12(4):242-3. PubMed ID: 21344779
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hepatitis C in patients infected with human immunodeficiency virus in the direct-acting antiviral era.
    Soriano V; Labarga P; Vispo E; Fernández-Montero JV; Barreiro P
    Infect Dis Clin North Am; 2012 Dec; 26(4):931-48. PubMed ID: 23083825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient.
    Rodríguez-Torres M
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1117-28. PubMed ID: 23199398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
    Bruno R; Fagiuoli S; Sacchi P
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):699-701. PubMed ID: 21905777
    [No Abstract]   [Full Text] [Related]  

  • 7. New pharmacotherapy for hepatitis C.
    Assis DN; Lim JK
    Clin Pharmacol Ther; 2012 Sep; 92(3):294-305. PubMed ID: 22850602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
    Terrault NA; McCaughan GW; Curry MP; Gane E; Fagiuoli S; Fung JYY; Agarwal K; Lilly L; Strasser SI; Brown KA; Gadano A; Kwo PY; Burra P; Samuel D; Charlton M; Pessoa MG; Berenguer M
    Transplantation; 2017 May; 101(5):945-955. PubMed ID: 28437387
    [No Abstract]   [Full Text] [Related]  

  • 9. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
    Stock PG; Fung J
    Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
    [No Abstract]   [Full Text] [Related]  

  • 10. Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus.
    Burra P; De Martin E
    Transplant Proc; 2011; 43(6):2455-6. PubMed ID: 21839292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of end-stage liver disease in HIV/hepatitis C virus co-infection.
    Spengler U
    Curr Opin HIV AIDS; 2011 Nov; 6(6):527-33. PubMed ID: 21918437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C virus-related cirrhosis: is antiviral treatment mandatory?].
    Castera L; Roulot D; Trinchet JC; Beaugrand M
    Gastroenterol Clin Biol; 2001 May; 25(5):509-13. PubMed ID: 11521104
    [No Abstract]   [Full Text] [Related]  

  • 13. International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
    Terrault NA; Berenguer M; Strasser SI; Gadano A; Lilly L; Samuel D; Kwo PY; Agarwal K; Curry MP; Fagiuoli S; Fung JYY; Gane E; Brown KA; Burra P; Charlton M; Pessoa MG; McCaughan GW
    Transplantation; 2017 May; 101(5):956-967. PubMed ID: 28437388
    [No Abstract]   [Full Text] [Related]  

  • 14. New Indications for Harvoni.
    Med Lett Drugs Ther; 2016 Jan; 58(1485):6. PubMed ID: 27099890
    [No Abstract]   [Full Text] [Related]  

  • 15. [Victrelis and Incivek against hepatitis C: some promising options].
    Sabourin G
    Perspect Infirm; 2012; 9(1):58-9. PubMed ID: 22295460
    [No Abstract]   [Full Text] [Related]  

  • 16. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
    Saab S; Hunt DR; Stone MA; McClune A; Tong MJ
    Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C.
    Burra P
    Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Merck and Vertex drugs raise standard of care in hepatitis C.
    Sheridan C
    Nat Biotechnol; 2011 Jul; 29(7):553-4. PubMed ID: 21747363
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the possible influence of hepatitis C virus and liver fibrosis on HIV type 1 immunological and virological outcomes.
    Collazos J; Cartón JA; Asensi V
    HIV Med; 2011 May; 12(5):308-15. PubMed ID: 20946441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
    Charlton M
    Hepatology; 2011 Jul; 54(1):3-5. PubMed ID: 21710471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.